Abstract
Quality assessment of primary studies to evaluate the reliability of study results is an essential and mandatory part of meta-analyses. It refers to the internal validity of a study and is described more precisely as assessing the risk of bias. Potential biases derive from selection of participants, data collection, analysis and selective reporting of study results. Quality assessment tools systematically collect information about study characteristics that may lead to bias in order to estimate the overall risk of bias. There are numerous tools available; they can be classified into checklists, scales and component ratings. Focusing on tools for assessing randomized controlled studies, an overview of covered elements of six selected generic tools is given. The Cochrane Collaboration’s tool is described in more detail because it incorporates some important features. Practical aspects of conducting quality assessments are discussed including the meaning and importance of detailed and precise guidance.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Abraham NS, Moayyedi P, Daniels B, Veldhuyzen van Zanten SJ (2004) Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 19:631–641
Al Khalaf MM, Thalib L, Doi SA (2011) Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses. J Clin Epidemiol 64:119–123
Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG (2012) Assessment of study quality for systematic reviews: a comparison of the Cochrane collaboration risk of bias tool and the effective public health practice project quality assessment tool: methodological research. J Eval Clin Pract 18:12–18
Balevi B (2011) Industry sponsored research may report more favourable outcomes. Evid Based Dent 12:5–6
Barnes DE, Bero LA (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279:1566–1570
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639
Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP (2006) Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol 59:697–703
Campbell MK, Elbourne DR, Altman DG (2004) CONSORT statement. Extension to cluster randomised trials. BMJ 328:702–708
Chan AW, Krleza-Jeric K, Schmid I, Altman DG (2004) Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Can Med Assoc J 171:735–740
Cho MK, Bero LA (1994) Instruments for assessing the quality of drug studies published in the medical literature. JAMA 272:101–104
Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, Laupacis A (1999) Assessing the quality of randomized trials. Reliability of the Jadad scale. Control Clin Trials 20:448–452
Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377–384
Dreier M, Borutta B, Stahmeyer J, Krauth C, Walter U (2010) Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany. GMS Health Technol Assess 6:Doc07
Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR (2008) Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3:e3081
Greenland S (1994) Invited commentary. A critical look at some popular meta-analytic methods. Am J Epidemiol 140:290–296
Haahr MT, Hrobjartsson A (2006) Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clin Trials 3:360–365
Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs SJ, Klassen TP (2009) Risk of bias versus quality assessment of randomised controlled trials. Cross sectional study. BMJ 339:b4012
Herbison P, Hay-Smith J, Gillespie WJ (2006) Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol 59:1249–1256
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011a) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
Higgins JPT, Altman DG, Sterne JAC (2011) Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from http://www.cochrane-handbook.org
Huwiler-Müntener K, Jüni P, Junker C, Egger M (2002) Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 287:2801–2804
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials. Is blinding necessary? Control Clin Trials 17:1–12
Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054–1060
Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46
Kjaergaard LL, Villumsen J, Cluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135:982–989
Kunz R, Oxman AD (1998) The unpredictability paradox. Review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 317:1185–1190
Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167–1170
Liddle J, Williamson M, Irwig L (1996) Method for evaluating research and guideline evidence. New South Wales Department of Health, Sydney
Lohr KN, Carey TS (1999) Assessing “best evidence”. Issues in grading the quality of studies for systematic reviews. Jt Comm J Qual Improv 25:470–479
Ludwig-Boltzmann Institut HTA. (Internes) Manual–Abläufe und Methoden Tl. 2. 2007. Wien, Ludwig Bolzmann Institut, Health Technology Assessment. HTA-Projektbericht, Nr. 006
Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P (2009) Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 302:977–984
McGauran N, Wieseler B, Kreis J, Schuler YB, Kolsch H, Kaiser T (2010) Reporting bias in medical research: a narrative review. Trials 11:37
Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S (1995) Assessing the quality of randomized controlled trials. An annotated bibliography of scales and checklists. Control Clin Trials 16:62–73
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609–613
Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, Pham B, Klassen TP (1999) Assessing the quality of reports of randomised trials. Implications for the conduct of meta-analyses. Health Technol Assess 3:1–98
Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869
National Health Service Public Health Resource Unit (2006) Critical appraisal skills programme: making sense of evidence. 10 questions to help you make sense of randomised controlled studies. Available from http://www.sph.nhs.uk/what-we-do/public-health-workforce/resources/critical-appraisals-skills-programme
Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schünemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD (2011) Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. doi:10.1002/14651858.MR000012.pub3
Oxman AD (1994) Checklists for review articles. BMJ 309:648–651
Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ (2006) Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295:1152–1160
Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC (2007) Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 36:847–857
Porta N, Bonet C, Cobo E (2007) Discordance between reported intention-to-treat and per protocol analyses. J Clin Epidemiol 60:663–669
Scottish Intercollegiate Guidelines Network (SIGN) (2011) SIGN 50 – a guideline developer’s handbook. Available from http://www.sign.ac.uk/guidelines/fulltext/50/index.html
Thomas BH, Ciliska D, Dobbins M, Micucci S (2004) A process for systematically reviewing the literature. Providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 1:176–184
University of Oxford (2005) Centre of Evidence Based Medicine (CEBM). Critical appraisal for therapy articles. Available from http://www.cebm.net/index.aspx?o=1157
Verhagen AP, De Vet HCW, de Bie RA, Kessels AGH, Boers M, Bouter LM, Knipschild PG (1998) The Delphi list. A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51:1235–1241
Verhagen AP, de Bie RA, Lenssen AF, de Vet HC, Kessels AG, Boers M, van den Brandt PA (2000) Impact of quality items on study outcome. Treatments in acute lateral ankle sprains. Int J Technol Assess Health Care 16:1136–1146
West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L (2002) Systems to rate the strength of scientific evidence. Evid Rep Technol Assess 47:1–11
Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J (2004) Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 8:1–234
Williamson PR, Gamble C (2005) Identification and impact of outcome selection bias in meta-analysis. Stat Med 24:1547–1561
Wood L, Egger M, Gluud LL, Schulz K, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336:601–605
Zaza S, Wright-De Aguero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH, Sosin DM, Anderson L, Carande-Kulis VG, Teutsch SM, Pappaioanou M (2000) Data collection instrument and procedure for systematic reviews in the guide to community preventive services. Task force on community preventive services. Am J Prev Med 18:44–74
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dreier, M. (2013). Quality Assessment in Meta-analysis. In: Doi, S., Williams, G. (eds) Methods of Clinical Epidemiology. Springer Series on Epidemiology and Public Health. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37131-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-37131-8_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37130-1
Online ISBN: 978-3-642-37131-8
eBook Packages: MedicineMedicine (R0)